share_log

Lake Street Reiterates Buy on Castle Biosciences, Maintains $32 Price Target

Benzinga ·  Jul 7, 2023 08:47

Lake Street analyst Thomas Flaten reiterates Castle Biosciences (NASDAQ:CSTL) with a Buy and maintains $32 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment